Torrey Growth & Income Advisors

Position in VCEL — Vericel Corp

CIK 2087822 DEL MAR, CA

Position in VCEL

as of Jun 30, 2026 · filed Jul 27, 2026 Compact

Position Value

$1,704,322

+$266,870 QoQ

Shares Held

38,308

-14.3% QoQ

Ownership

0.075%

of shares outstanding

% of Portfolio

0.61%

of 13F equity value

Holder Rank

#112

of 317 holders

Holding Since

Sep 2025

4 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Torrey Growth & Income Advisors holds $6,964,754 across 5 Biotechnology names. VCEL ranks #2 (24.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	4,710	$2,339,598
2	VCEL	Vericel Corp This page	38,308	$1,704,322
3	NTLA	Intellia Therapeutics, Inc.	70,669	$1,195,719
4	IBRX	ImmunityBio, Inc.	118,860	$1,040,619
5	CADL	Candel Therapeutics, Inc.	66,456	$684,496

4 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,704,322	38,308	-14.3%	Shares	Sole	2026-07-27
2026-03-31	$1,437,452	44,683	-2.2%	Shares	Sole	2026-04-21
2025-12-31	$1,645,044	45,683	-41.2%	Shares	Sole	2026-02-17
2025-09-30	$2,444,684	77,683	—	Shares	Sole	2025-11-13
No filing history on record for this holder in this stock.